Our research

Fight for Sight funds pioneering research to prevent sight loss and treat eye disease in adults and children. Each year, we provide a range of funding opportunities for research teams based in the UK who are attached to recognised academic or medical institutions. You can read summaries of our research projects below.

Filter

By research category

All

Please enable Javascript in your browser to search research content.

Display



How does blurred near vision affect children's progress at school?

Understanding more about the links between eyesight, attention and reading ability

September 14 - September 17
Find out more

Finding the genetic cause of uncontrolled eye movements in children

Towards an NHS test for infantile nystagmus

January 17 - January 18
Find out more

How is depth perception affected by involuntary eye movements?

A new test to find out how people with infantile nystagmus and albinism manage everyday activities that rely on 3D vision

January 17 - January 18
Find out more

How do vision and eye movements develop in young children with nystagmus?

Helping children have the best chance to develop normal vision.

February 16 - January 17
Find out more

What’s the effect of childhood-onset nystagmus on the ability to balance?

Getting better information and advice in the clinic.

April 15 - March 16
Find out more

Why does the world look like it's moving when it's not, in people with some types of nystagmus?

Using an optical illusion to understand how the brain corrects for eye movement

June 14 - September 15
Find out more

Nystagmus Stabilisation with Virtual Reality Technology

Developing an image stabilisation technology in virtual reality to treat oscillopsia, a symptom of Nystagmus.

December 17 - May 18
Find out more


Latest news

Researchers investigate how our natural ‘body clock’ could influence short sightedness
Read full story
Early intervention can improve development and reduce mental health issues for babies with visual im…
Read full story
Awareness campaign: new targeted treatment could help prevent sight loss in children with eye cancer…
Read full story
European Commission approves Luxturna to treat patients with inherited retinal disease
Read full story